Biochemical indicators associated with metabolic disorders during the first six months after kidney transplantation at 108 Military Central Hospital
Main Article Content
Abstract
Objective: To describe metabolic disorders and associated factors during the first 6 months post-kidney transplantation at the 108 Military Central Hospital. Methods: A retrospective longitudinal cohort study was conducted on 131 kidney transplant recipients. Anthropometric and biochemical parameters were collected pre-transplantation and followed up for at least 6 months post-surgery. Results: Pre-transplantation, 56.5% of patients had a normal BMI, while 20.6% were underweight (BMI < 18.5kg/m²). The prevalence of patients with at least one pre-transplant metabolic disorder was 63.4%, with dyslipidemia and hyperuricemia accounting for 45.0% and 29.8%, respectively. Post-transplantation, the rate of hyperglycemia increased significantly at 1 month (23.7%) compared to baseline, followed by a gradual decline. Hypertriglyceridemia emerged as the most common lipid abnormality, particularly during the early post-transplant phase. Analysis of associated factors revealed that pre-transplant BMI statistically influenced metabolic disorders at 3 months post-transplantation (p<0.05). Conclusion: Metabolic disorders are highly prevalent among kidney transplant recipients, particularly in the early post-transplant period. Routine monitoring of metabolic indicators, enhanced nutritional counseling, and lifestyle modifications are essential for these patients.
Article Details
References
2. Ellen Busink, Dana Kendzia, Fatih Kircelli (2023) A systematic review of the cost-effectiveness of renal replacement therapies, and consequences for decision-making in the end-stage renal disease treatment pathway. The European Journal of Health Economics 24: 377-392.
3. Võ Tam, Nguyễn Thị Thùy Linh, Nguyễn Thị Lộc, Nguyễn Thanh Minh (2015) Nghiên cứu rối loạn và hiệu quả điều trị tăng lipid máu trên bệnh nhân sau ghép thận tại Bệnh viện Trung ương Huế. JMP 30: 58-65.
4. Nguyễn Đức Thuận, Đặng Thành Chung (2021) Nghiên cứu tình trạng thừa cân béo phì và mối liên quan đến đái tháo đường sau ghép thận. VMJ 500(1): 1.
5. Nguyễn Tất Đạt (2024) Các thay đổi tim mạch – chuyển hóa trên bệnh nhân sau ghép thận | nghiên cứu khoa học. Luận án Tiến sĩ. Đại học Y dược Thành phố Hồ Chí Minh; 2024. Accessed April 24, 2025. https://nckh.net/index.php/de-tai/cac-thay-doi-tim-mach-chuyen-hoa-tren-benh-nhan-sau-ghep-than
6. Nguyễn Thị An Thủy, Nguyễn Trung Dũng (2023) Tìm hiểu nồng độ acid uric máu ở bệnh nhân sau ghép thận tại Bệnh viện Bạch Mai. Tạp chí Y học Việt Nam 527(1).
7. American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes 2025. Diabetes Care. 2024;48(Supplement_1):S27-S49. doi:10.2337/dc25-S002
8. Chadban SJ, Ahn C, Axelrod DA et al (2020) KDIGO Clinical Practice Guideline on the Evaluation and Management of Candidates for Kidney Transplantation. Transplantation 104(4S1): 11-103. doi:10.1097/TP.0000000000003136
9. Meier-Kriesche HU, Schold JD, Srinivas TR, Kaplan B (2004) Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates Over the Most Recent Era. American Journal of Transplantation 4(3): 378-383. doi:10.1111/j.1600-6143.2004.00332.x
10. Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients - American Journal of Transplantation. Accessed May 21, 2026. https://www.amjtransplant.org/article/S1600-6135(22)01933-5/fulltext
11. Abraham G, Anupama S, Parthasarathy R, Anupama P, Mathew M (2020) Malnutrition in kidney transplantation: Our experience and review of literature. Indian Journal of Transplantation 14: 15. doi:10.4103/ijot.ijot_40_19
12. Kopple JD (2001) National Kidney Foundation K/DOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure. American Journal of Kidney Diseases 37(1-2):66-70. doi:10.1053/ajkd.2001.20748
13. Miyasato Y, Hanna RM, Morinaga J, Mukoyama M, Kalantar-Zadeh K (2023) Prognostic Nutritional Index as a Predictor of Mortality in 101,616 Patients Undergoing Hemodialysis. Nutrients 15(2): 311. doi:10.3390/nu15020311
14. Vaziri ND (2006) Dyslipidemia of chronic renal failure: the nature, mechanisms, and potential consequences. American Journal of Physiology-Renal Physiology 290(2): 262-272. doi:10.1152/ajprenal.00099.2005
15. Sharif A, Hecking M, de Vries APJ et al (2014) Proceedings From an International Consensus Meeting on Posttransplantation Diabetes Mellitus: Recommendations and Future Directions. Am J Transplant 14(9): 1992-2000. doi:10.1111/ajt.12850
16. Hosseini MS, Rostami Z, Einollahi B (2013) Dyslipidemia after kidney transplantation and correlation with cyclosporine level. Nephro-Urology Monthly 5(3): 831.
17. Vries APJD, Bakker SJL, Son WJV et al (2004) Metabolic Syndrome Is Associated with Impaired Long-term Renal Allograft Function; Not All Component criteria Contribute Equally. American Journal of Transplantation 4(10): 1675-1683. doi:10.1111/j.1600-6143.2004.00558.x
18. Kalantar E, Khalili N, Hossieni MS, Rostami Z, Einollahi B (2011) Hyperuricemia After Renal Transplantation. Transplantation Proceedings 43(2): 584-585. doi:10.1016/j.transproceed.2011.01.062
19. Fellström B, Jardine AG, Soveri I et al (2005) Renal Dysfunction as a Risk Factor for Mortality and Cardiovascular Disease in Renal Transplantation: Experience from the Assessment of Lescol in Renal Transplantation Trial. Transplantation 79(9): 1160. doi:10.1097/01.TP.0000160764.35083.B8
20. Cosio FG, Pesavento TE, Kim S, Osei K, Henry M, Ferguson RM (2002) Patient survival after renal transplantation: IV. Impact of post-transplant diabetes. Kidney international 62(4): 1440-1446.
ISSN: 1859 - 2872